Fremont, CANCT07236099Now EnrollingIRB Ready

Prurigo Nodularis (PN) Clinical Trial in Fremont, CA

Access cutting-edge prurigo nodularis (pn) treatment through this phase 2 clinical trial at a research site in Fremont. Study-provided care at no cost to qualified participants.

Sponsored by Beijing InnoCare Pharma Tech Co., Ltd.

Quick Self-Assessment

See if you qualify for this Fremont location

Preparing your pre-screening questions…

Expert Care in Fremont

Access prurigo nodularis (pn) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related prurigo nodularis (pn) treatment provided free

Apply for This Fremont Location

Check if you qualify for this prurigo nodularis (pn) clinical trial in Fremont, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fremont

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fremont site if eligible
  4. 4Begin participation

About This Prurigo Nodularis (PN) Study in Fremont

Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Who Can Participate

Inclusion Criteria

Voluntarily sign informed consent forms before any investigational procedure(s) are performed.
Male or female aged between 18 and 75 years at the time of signing the informed consent.
Clinical diagnosis of PN by a dermatologist for at least 3 months before the Screening visit.
At least 20 pruriginous lesions on the entire body with a bilateral distribution (on both legs, and/or both arms and/or trunk) at both screening and the baseline (Day 1) visits.
PP NRS score ≥ 7 at both screening and the baseline (Day 1) visits.
IGA-CPG-S score ≥ 3 at both the screening and the baseline (Day 1) visits.
History of inadequate response to topical corticosteroid of medium or higher potency or for whom topical treatments are otherwise medically inadvisable (e.g., because of important side effects or safety risks). Willingness to avoid pregnancy or fathering children

Exclusion Criteria

Patients with a documented AD severity moderate to severe presence of skin morbidities other than PN and mild AD that may interfere with the assessment of the study outcomes. PN secondary to medications .
Any uncontrolled or serious disease, or any medical, psychological, or surgical condition including relevant laboratory abnormalities at screening that may either interfere with the interpretation of the clinical trial results and/or, in the investigator's judgment, would adversely affect the patient's participation in the study. Active chronic or acute infection participant not suitable for participation, whatever the reason, as judged by the Investigator, including medical or clinical conditions, or participants potentially at risk of noncompliance to study procedures.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fremont?

Yes, this clinical trial (NCT07236099) has an active research site in Fremont, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Prurigo Nodularis (PN) Treatment Options in Fremont, CA

If you're searching for prurigo nodularis (pn) treatment options in Fremont, CA, this clinical trial (NCT07236099) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fremont research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced prurigo nodularis (pn) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all prurigo nodularis (pn) clinical trials near you to find additional studies recruiting in your area.

More Prurigo Nodularis Trials in Fremont, CA

See all prurigo nodularis clinical trials recruiting in Fremont — not just this study.

Browse Prurigo Nodularis Trials in Fremont →

Browse More Trials by Condition

Prurigo Nodularis TrialsAll Conditions →

Ready to Join in Fremont?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fremont, CA